Home > News > Latest > Sucampo Pharmaceuticals (SCMP) Earns News Impact Rating of 0.24

Sucampo Pharmaceuticals (SCMP) Earns News Impact Rating of 0.24

News articles about Sucampo Pharmaceuticals (NASDAQ:SCMP) have trended somewhat positive on Wednesday, AlphaOne reports. The research firm, a service of Accern.

Spotlight

Other News

Dom Nicastro | April 03, 2020

More Trending news

Spotlight

Resources

Introducing EU Annex 1: Understanding the Newest Regulatory Requirements

Whitepaper

Line Optimizer - digital guided workflows for optimized pharma production operations

Video

Artificial Intelligence in Drug Manufacturing

Whitepaper

Introducing EU Annex 1: Understanding the Newest Regulatory Requirements

Whitepaper

Line Optimizer - digital guided workflows for optimized pharma production operations

Video

Artificial Intelligence in Drug Manufacturing

Whitepaper